Teva Pharmaceutical Industries (NYSE:TEVA) announces the immediate donation of 6M doses of malaria med hydroxychloroquine sulfate tablets through wholesalers to U.S. hospitals to meet the demand related to COVID-19.
It expects to ship all 6M tablets by the end of March and more than 10M tablets within a month.
The company says it is actively looking across its portfolio of products to determine if it can provide any others that may help the medical community during the outbreak.
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that Matthew S. Rheingold has been elevated from
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that partners Thomas J. Snyder and Matheu D. Nunn
Mark H. Anania, a partner at McCarter & English, LLP, has been named President of the New Jersey Intellectual Property Law Association
Cohen Seglias Pallas Greenhall & Furman PC is pleased to announce that Anthony H. Chwastyk has joined the
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2025 citybuzz
